Wasatch Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Wasatch Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-81,450	Closed	-$3.38M	–	240
2024 Q2	$3.38M	Sell	81,450 -5,925	-7%	-$265K	0.02%	209
2024 Q1	$4.74M	Hold	87,375	–	–	0.02%	202
2023 Q4	$4.48M	Buy	87,375 +3,500	+4%	+$184K	0.02%	202
2023 Q3	$4.87M	Buy	83,875 +6,500	+8%	+$398K	0.03%	203
2023 Q2	$4.95M	Buy	77,375 +4,000	+5%	+$268K	0.03%	208
2023 Q1	$5.09M	Buy	73,375 +10,000	+16%	+$705K	0.03%	206
2022 Q4	$4.56M	Sell	63,375 -4,000	-6%	-$302K	0.03%	203
2022 Q3	$4.79M	Hold	67,375	–	–	0.03%	202
2022 Q2	$5.19M	Buy	67,375 +4,000	+6%	+$305K	0.03%	202
2022 Q1	$4.63M	Buy	63,375 +8,000	+14%	+$537K	0.02%	223
2021 Q4	$3.45M	Buy	55,375 +4,000	+8%	+$235K	0.01%	240
2021 Q3	$3.04M	Sell	51,375 -87	-0.2%	-$5.73K	0.01%	261
2021 Q2	$3.44M	Buy	+51,462	New	+$3.36M	0.01%	259

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wasatch Advisors's BMY Position: Q3 2024 in Review

Wasatch Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 81,450 shares — an estimated $3.38M sold.

Wasatch Advisors first reported a position in BMY in Q2 2021 and held it in 13 quarters. The position peaked at $5.19M in Q2 2022. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Wasatch Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Wasatch Advisors sold 81,450 Bristol-Myers Squibb shares in Q3 2024, an estimated $3.38M.
Wasatch Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 13 quarters.
Wasatch Advisors's Bristol-Myers Squibb position peaked at $5.19M in Q2 2022.
2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Wasatch Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.